AstraZeneca, Lupin Soothe Nexium Patent Fight

Law360, New York (January 26, 2012, 8:10 PM EST) -- Pharmaceutical giants AstraZeneca AB, Merck Sharp & Dohme Corp. and KBI Inc. reached a settlement Thursday with Indian drugmaker Lupin Ltd. in a patent dispute over stomach acid reflux drug Nexium.

U.S. District Judge Joel A. Pisano signed off on the settlement agreement — whose terms were not publicly disclosed — dismissing all claims in the dispute without prejudice and without costs or attorneys’ fees to any of the parties in the dispute.

Sweden-based AstraZeneca and New Jersey-based KBI had sued Lupin in October 2009, claiming...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.